ArticleFrontiers in oncology2026
Integrated bioinformatics and experimental validation identifies SOX2 as a key therapeutic target for chronic atrophic gastritis/gastric cancer-depression comorbidity.
Yang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.